Biotech Values

[Double_Bagel]

Sarepta Ready to Provide Ebola Drug if Needed

Wow! CG stepping up. Nice article in Barrons (published at 7:05 pm -- sending the stock up to 22.5 after hours). So, first Mapp and now Sarepta being aggressive while TKMR is in hiding (or at least it appears that way for now). Only this time I am not complaining if SRPT does benefit from this

http://online.barrons.com/news/articles/SB50001424053111904329504580072041992787302

Sarepta Ready to Provide Ebola Drug if Needed
Drug company stopped development two years ago, but has enough supply to treat a few dozen patients.

Sarepta Therapeutics ( SRPT ) stands ready to provide its Ebola drug if the U.S. government asks for it, according to Sarepta CEO Chris Garabedian.

Sarepta, which is best known for ongoing efforts to gain regulatory approval for eteplirsen, a drug for muscular dystrophy, also has developed a treatment for Ebola that has had success in combatting the deadly disease in primates. The drug's development stopped two years ago when government funding dried up, but Sarepta still has enough of the drug to potentially treat a few dozen patients. The company is one of only a few companies with a potential treatment for the disease.

"We have a drug that that could be deployed and shipped," Garabedian told Barron's. He said any use of the drug would require waivers and approval from the Department of Defense, which paid for the development of the drug, as well as the Food and Drug Administration. The Sarpeta Ebola drug showed survival rates of 60% to 80% in primates, versus a zero percent survival rate among untreated animals.